Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism Bcl-2 inhibitors(Apoptosis regulator Bcl-2 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Atherosclerosis | Discovery | - | 15 Feb 2024 | |
| Chronic idiopathic thrombocytopenic purpura | Discovery | - | 15 Feb 2024 | |
| Endocrinology and Metabolic Disease | Discovery | - | 15 Feb 2024 | |
| Endometriosis | Discovery | - | 15 Feb 2024 | |
| Immune System Diseases | Discovery | - | 15 Feb 2024 | |
| Irritable Bowel Syndrome | Discovery | - | 15 Feb 2024 | |
| Labyrinth Diseases | Discovery | - | 15 Feb 2024 | |
| Neoplasms | Discovery | - | 15 Feb 2024 | |
| Nervous System Diseases | Discovery | - | 15 Feb 2024 | |
| Other Diseases | Discovery | - | 15 Feb 2024 |





